Technology giant Tencent Holdings Limited (00700.HK) launched a US$100 million Global Anti-Pandemic Fund to support international efforts against COVID-19.
Iaso Biotherapeutics, a Nanjing, China-based clinical-stage biotechnology company, closed a $60m series B financing.
Y-Platform, a Chinese multi-channel video network, completed a $3.5m Series A funding round.
Neolix, a Chinese autonomous driving vehicle company, raised nearly RMB 200M in Series A+ funding.
Fenbeitong, a Chinese renowned corporate expense management startup, raised $36M in Series B+ financing.
Harbour BioMed, a Cambridge, MA- Rotterdam, The Netherlands and Suzhou, China-based global, clinical stage biopharmaceutical company, closed its $75m Series B+ round of financing.
Whales English, a Beijing, China-based brand of online K-12 English group classes, completed its RMB100m Series B financing.
CANbridge Pharmaceuticals Inc., a Beijing, China-based biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, completed a US$98m Series D financing.
Mastercard (NYSE: MA) has received in-principle approval from the People’s Bank of China (PBOC) to begin formal preparations to set up a domestic bankcard clearing institution in China.
Today’s internet industry ranks as one of the highest-grossing businesses for global players. China is on the mainstream of digital technology as the country is at the forefront of the tech players around the world. Getting ahead of the industry requires business people to stay on top of their game by maximizing their professional value. […]
Adagene, Inc., a Chinese clinical-stage oncology immunotherapy company, completed a $69m Series D financing.
Unicorn Capital Partners, a venture capital fund-of-funds manager, raised Unicorn Capital Partners Fund III, L.P., which closed at US$350M.
Hesai, a Chinese LiDAR technology manufacturer, closed its series C funding totaling USD173M.
CF PharmTech, Inc., a Shuzhou, China-based pharmaceutical company, raised $90m in Series E funding.
AInnovation, a Beijing, China-based AI solutions provider, closed a Series B financing round of nearly 400m yuan (approx. US$60m).